Martin & Co. Inc. TN purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 15,985 shares of the company’s stock, valued at approximately $2,054,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Frazier Financial Advisors LLC bought a new position in shares of Merck KGaA in the second quarter worth $25,000. Rakuten Securities Inc. acquired a new position in shares of Merck KGaA during the second quarter valued at $27,000. Bard Associates Inc. acquired a new position in shares of Merck KGaA during the second quarter valued at $60,000. Kilter Group LLC bought a new stake in shares of Merck KGaA during the second quarter valued at about $62,000. Finally, Addison Advisors LLC bought a new stake in shares of Merck KGaA during the second quarter valued at about $90,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
MKGAF stock opened at $163.21 on Friday. The company has a 50-day simple moving average of $162.62 and a 200 day simple moving average of $148.46. The company has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
